Please assess the completion status of the following clinical trial:

Trial Title: Health Economics Evaluation of Percutaneous Vertebroplasty Compared to Radiation Therapy in Patients With Painful Spine Metastases.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age ≥ 18 years at the day of consenting to the study~* Patient with at least a painful spine metastasis confirmed by MRI / CT scan,~* Localized pain at the lesion ≥ 4 (VAS),~* Bone axial metastasis localised on ≤ 6 different vertebrae,~* Histologically established diagnosis of cancer (lung, kidney, breast, prostate, melanoma, soft tissue sarcomas) other than hematologic malignancy, myeloma, brain tumor, germ cell tumor and bone sarcomas~* ECOG performance status 0 to 2 (Appendix 2)~* Minimum life expectancy of 6 months (Tokuhashi score \> 8 )~* Ability to understand and willingness for follow-up visits.~* Covered by a medical insurance~* Signed and dated informed consent document indicating that the patient has been informed of all the pertinent aspects of the trial prior to enrolment~Exclusion Criteria:~* Solitary metastasis~* SBRT indication~* Contra-indication to vertebroplasty~* Previous radiotherapy for pain management in the same area.~* Patient unable to lie prone~* Neurological deficit due to spinal cord compression,~* Active infection,~* Bleeding risk (platelets \< 50000 and PTT \> 1.5\*ULN),~* Risk of vertebral collapse (SINS score ≥ 13),~* Impossible follow-up for social, geographical, familial or psychological reasons,~* Patient deprived of freedom,~* Patient enrolled in another experimental surgical trial, with therapeutic endpoint,~* Pregnant or breastfeeding women,Pregnant or breastfeeding women (mandatory negative serum or urinary pregnancy test at study entry for all women of childbearing potential

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm A (Type: EXPERIMENTAL): Percutaneous vertebroplasty
- Arm B (Type: EXPERIMENTAL): External radiotherapy

Based on this trial design, predict the completion outcome and termination type (if applicable).